Follow
Selcuk Dagdelen
Selcuk Dagdelen
Verified email at hacettepe.edu.tr
Title
Cited by
Cited by
Year
Liraglutide and cardiovascular outcomes in type 2 diabetes
SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ...
New England Journal of Medicine 375 (4), 311-322, 2016
77572016
Liraglutide and renal outcomes in type 2 diabetes
JFE Mann, DD Ørsted, K Brown-Frandsen, SP Marso, NR Poulter, ...
New England Journal of Medicine 377 (9), 839-848, 2017
13232017
Semaglutide and cardiovascular outcomes in obesity without diabetes
AM Lincoff, K Brown-Frandsen, HM Colhoun, J Deanfield, SS Emerson, ...
New England Journal of Medicine 389 (24), 2221-2232, 2023
10752023
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
N Chaturvedi, M Porta, R Klein, T Orchard, J Fuller, HH Parving, R Bilous, ...
The Lancet 372 (9647), 1394-1402, 2008
5512008
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
AK Sjølie, R Klein, M Porta, T Orchard, J Fuller, HH Parving, R Bilous, ...
The Lancet 372 (9647), 1385-1393, 2008
5442008
Metabolik sendrom klavuzu
M Arslan, A Atmaca, G Ayvaz, N Başkal, Z Beyhan, E Bolu, S Can, ...
Türkiye endokrinoloji ve metabolizma derneği, 211-219, 2009
1072009
Increased thyroid cancer risk in acromegaly
S Dagdelen, N Cinar, T Erbas
Pituitary 17, 299-306, 2014
972014
Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis
S Dagdelen, D Sener, M Bayraktar
Advances in Therapy 24, 1314-1320, 2007
692007
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients
S Dogan, A Atmaca, S Dagdelen, B Erbas, T Erbas
Endocrine 45, 114-121, 2014
642014
Follow-up of pregnancy in acromegalic women: different presentations and outcomes
A Atmaca, S Dagdelen, T Erbas
Experimental and clinical endocrinology & diabetes 114 (03), 135-139, 2006
632006
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa
F Giorgino, S Bhana, L Czupryniak, S Dagdelen, GR Galstyan, A Janež, ...
diabetes research and clinical practice 172, 108617, 2021
542021
Endocrine involvement in systemic amyloidosis
D Ozdemir, S Dagdelen, T Erbas
Endocrine Practice 16 (6), 1056-1063, 2010
542010
Clinical characteristics and outcomes of COVID‐19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)
A Sonmez, I Demirci, C Haymana, I Tasci, S Dagdelen, S Salman, N Ata, ...
Journal of diabetes 13 (7), 585-595, 2021
512021
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
J Deanfield, S Verma, BM Scirica, SE Kahn, SS Emerson, D Ryan, ...
The Lancet 404 (10454), 773-786, 2024
452024
Peroxisome proliferator-activated receptor-γ: novel therapeutic target linking adiposity, insulin resistance, and atherosclerosis
A Kepez, A Oto, S Dagdelen
BioDrugs 20, 121-135, 2006
452006
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials
M Porta, JW Hainer, SO Jansson, A Malm, R Bilous, N Chaturvedi, ...
Diabetologia 54, 1298-1303, 2011
402011
Volatile Composition, Antioxidant and Antimicrobial Activities of Herbal Plants Used in the Manufacture of V an Herby (OTLU) Cheese
S Dagdelen, T Bilenler, G Durmaz, I Gokbulut, AA Hayaloglu, I Karabulut
Journal of Food Processing and Preservation 38 (4), 1716-1725, 2014
382014
Cavernous sinus invasion might be a risk factor for apoplexy
N Cinar, Y Tekinel, S Dagdelen, H Oruckaptan, F Soylemezoglu, T Erbas
Pituitary 16, 483-489, 2013
352013
Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly
M Dural, G Kabakcı, N Çınar, T Erbaş, U Canpolat, KM Gürses, ...
Pituitary 17, 163-170, 2014
322014
Use of SGLT2 inhibitors during Ramadan: an expert panel statement
M Hassanein, A Bashier, H Randeree, M Abouelmagd, W AlBaker, ...
diabetes research and clinical practice 169, 108465, 2020
302020
The system can't perform the operation now. Try again later.
Articles 1–20